1887

Journal of General Virology header logo

Volume 80, Issue 4

Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. Free

Abstract

The long control region (LCR) and the E2 protein of human papillomaviruses (HPV) are the most important viral factors regulating transcription of the viral oncogenes E6 and E7. Sequence variation within these genomic regions may have an impact on the oncogenic potential of the virus. Sequence variation in the LCR and in the E2 gene of human papillomavirus type 16 (HPV-16) isolates originating from cervical cancer patients from East Hungary was studied. In 30 samples, sequencing and/or single-strand conformation polymorphism analysis revealed variants belonging to the European variant lineage of HPV-16. These variants differed from the reference European clone only slightly in their E2 and LCR sequences. Three samples represented variants belonging to the Asian-American group. These differed from the published reference sequence at several positions in the LCR and E2 regions. Compared to the reference clone, the LCR clones of the European isolates showed very similar transcriptional activities, while that of an Asian-American isolate had ~ 1.7-fold increased activity. Most of the increased activity of the Asian-American isolate could be ascribed to nucleotide changes found at the 3′ end of the LCR (nt 7660-7890). The transcriptional transactivation potentials of the HPV-16 E2 isolates differed only slightly from each other, and the differences seemed to be independent of the taxonomic position of the isolates.

  • Received:
  • Accepted:
  • Published Online:
© Journal of General Virology 1999
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-4-1035
1999-04-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/4/0801035a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-4-1035&mimeType=html&fmt=ahah

References

  1. Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. (editors) 1995 Current Protocols in Molecular Biology New York: John Wiley;
     [Google Scholar]
  2. Bouvard V., Storey A., Pim D., Banks L. 1994; Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes. EMBO Journal 13:5451–5459
     [Google Scholar]
  3. Chen Z., Storthz K. A., Shillitoe J. 1997; Mutations in the long control region of human papillomavirus DNA in oral cancer cells, and their functional consequences. Cancer Research 57:1614–1619
     [Google Scholar]
  4. Chiang C.-M., Ustav M., Stenlund A., Ho T. F., Broker T. R., Chow L. T. 1992; Viral E1 and E2 proteins support replication ofhomologous and heterologous papillomaviral origins. Proceedings of the National Academy of Sciences, USA 89:5799–5803
     [Google Scholar]
  5. Chong T., Apt D., Gloss B., Isa M., Bernard H. U. 1991; The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NFI, and AP-1 participate in epithelial cell-specific transcription. Journal of Virology 65:5933–5943
     [Google Scholar]
  6. Das B. C., Sharma J. K., Gopalakrishna V., Luthra U. K. 1992; Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. Journal of General Virology 73:2327–2336
     [Google Scholar]
  7. Desaintes C., Demeret C. 1996; Control of papillomavirus DNA replication and transcription. Seminars in Cancer Biology 7:339–347
     [Google Scholar]
  8. Dong X.-P., Stubenrauch F., Beyer-Finkler E., Pfister H. 1994; Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. International Journal of Cancer 58:803–808
     [Google Scholar]
  9. Doorbar J., Ely S., Sterling J., McLean C., Crawford L. 1991; Specific interaction between HPV–16 E1–E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature 352:824–827
     [Google Scholar]
  10. Dyson N., Howley P. M., Munger K., Harlow E. 1989; The human papillomavirus–16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934–937
     [Google Scholar]
  11. Giri I., Yaniv M. 1988; Structural and mutational analysis of E2 trans activating proteins of papillomaviruses reveals three distinct functional domains. EMBO Journal 7:2823–2829
     [Google Scholar]
  12. Hecht J. L., Kadish A. S., Jiang G., Burk R. D. 1995; Genetic characterisation of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. International Journal of Cancer 60:369–376
     [Google Scholar]
  13. Ishiji T., Lace M. J., Parkkinen S., Anderson R. D., Haugen T. H., Cripe T. P., Xiao J.-H., Davidson I., Chambon P., Turek L. P. 1992; Transcriptional enhancer factor (TEF)-1 and its cell–specific coactivator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. EMBO Journal 11:2271–2281
     [Google Scholar]
  14. Mittal R., Pater A., Pater M. M. 1993; Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA-protein interactions. Journal of Virology 67:5656–5659
     [Google Scholar]
  15. O’Connor M., Bernard H. U. 1995; Oct-1 activates the epithelial- specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element. Virology 207:77–88
     [Google Scholar]
  16. O’Connor M. J., Tan S.-H., Tan C.-H., Bernard H.-U. 1996; YY1 represses human papillomavirus type 16 transcription by quenching -1 activity. Journal of Virology 70:6529–6539
     [Google Scholar]
  17. Sakai H., Yasugi T., Benson J. D., Dowhanick J. J., Howley P. M. 1996; Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions. Journal of Virology 70:1602–1611
     [Google Scholar]
  18. Scheffner M., Werness B. A., Huibregtse J. M., Levine A. J., Howley P. M. 1990; The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129–1136
     [Google Scholar]
  19. Schneider A. 1993; Pathog enesis of genital HPV infection. Genitourinary Medicine 69:165–173
     [Google Scholar]
  20. Seedorf K., Krammer G., Durst M., Suhai S., Rowekamp W. G. 1985; Human papillomavirus type 16 DNA sequence. Virology 145:181–185
     [Google Scholar]
  21. Stoppler M. C., Ching K., Stoppler K., Clancy K., Schlegel R., Icenogle J. 1996; Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. Journal of Virology 70:6987–6993
     [Google Scholar]
  22. Tan S.-H., Leong L. E.-C., Walker P. A., Bernard H. U. 1994; The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. Journal of Virology 68:6411–6420
     [Google Scholar]
  23. Turek L. P. 1994; The structure, function, and regulation of papilloma viral genes in infection and cervical cancer. Advances in Virus Research 44:305–356
     [Google Scholar]
  24. Villa L. L., Schlegel R. 1991; Differences in transformation activity between HPV-18 and HPV-16 map to the viral LCR-E6-E7 region. Virology 181:374–377
     [Google Scholar]
  25. Woodworth C. D., Doniger J., DiPaolo J. A. 1989; Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. Journal of Virology 63:159–164
     [Google Scholar]
  26. Xi L. F., Demers W., Kiviat N. B., Kuypers J., Beckmann A. M., Galloway D. A. 1993; Sequence variation in the noncoding region of human papillomavirus type 16 detected by single-strand conformation polymorphism analysis. Journal of Infectious Diseases 168:610–617
     [Google Scholar]
  27. Xi L. F., Koutsky L. A., Galloway D. A., Kuypers J., Hughes J. P., Wheeler C. M., Holmes K. K., Kiviat N. B. 1997; Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. Journal of the National Cancer Institute 89:796–802
     [Google Scholar]
  28. Yamada T., Manos M. M., Peto J., Greer C. E., Munoz N., Bosch F. X., Wheeler C. M. 1997; Human papillomavirus type 16 sequence variation in cervical cancers: a world-wide perspective. Journal of Virology 71:2463–2472
     [Google Scholar]
  29. Zehbe I., Wilander E., Delius H., Tommasino M. 1998; Human papillomavirus type 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Research 58829–833
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-4-1035
Loading
Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16.
J. Gen. Virol. 80, 1035 (1999); https://doi.org/10.1099/0022-1317-80-4-1035
/content/journal/jgv/10.1099/0022-1317-80-4-1035
/content/journal/jgv/10.1099/0022-1317-80-4-1035
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error